Locally Advanced Pancreatic Cancer With KRAS G12D Mutation
1 clinical trials · Condition
◉ Watch Locally Advanced Pancreatic Cancer With KRAS G12D Mutation
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer (NCT07438106) | The First Affiliated Hospital with Nanjing Medical University | 2026-01-28 |
Track Locally Advanced Pancreatic Cancer With KRAS G12D Mutation automatically
Every clearance here is in the API, with alerts when new ones post.